⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OGN News
Organon & Co.
Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA ® (ustékinumab), un biosimilaire de référence à STELARA ® (ustékinumab) au Canada
businesswire.com
OGN
Organon et Samsung Bioepis élargissent leur entente pour la commercialisation de PYZCHIVA® (ustékinumab), un biosimilaire de référence à STELARA® (ustékinumab) au Canada
businesswire.com
OGN
Halper Sadeh LLC is Investigating Whether LPRO, NUVL, OGN, SUNE are Obtaining Fair Deals for their Shareholders
globenewswire.com
LPRO
NUVL
OGN
SUNE
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG), Organon & Co. (NYSE – OGN)
globenewswire.com
SLP
ROKU
TBRG
OGN
Form 8-K
sec.gov
OGN
Organon Secures US Food and Drug Administration Approval Expanding Indications for TOFIDENCE® (tocilizumab-bavi) in Cytokine Release Syndrome (CRS) and Pediatric COVID-19
businesswire.com
OGN
Halper Sadeh LLC is Investigating Whether NUVL, SUNE, OGN, TMHC are Obtaining Fair Deals for their Shareholders
globenewswire.com
NUVL
SUNE
OGN
TMHC
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Nuvalent, Inc. (Nasdaq – NUVL), SUNation Energy, Inc. (Nasdaq – SUNE), Organon & Co. (NYSE – OGN), Taylor Morrison Home Corporation (NYSE – TMHC)
globenewswire.com
NUVL
SUNE
OGN
TMHC
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia
globenewswire.com
OGN
オルガノン、ISPOR 2026でアクセスと価値に関する新たな研究成果を発表へ
businesswire.com
OGN